Page last updated: 2024-10-20

pyrazinamide and Stevens-Johnson Syndrome

pyrazinamide has been researched along with Stevens-Johnson Syndrome in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Porter, M1
Choshi, P1
Pedretti, S1
Chimbetete, T1
Smith, R1
Meintjes, G1
Phillips, E1
Lehloenya, R1
Peter, J1
Kura, MM1
Hira, SK1

Trials

1 trial available for pyrazinamide and Stevens-Johnson Syndrome

ArticleYear
Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: role of desensitization.
    International journal of dermatology, 2001, Volume: 40, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antitubercular Age

2001

Other Studies

1 other study available for pyrazinamide and Stevens-Johnson Syndrome

ArticleYear
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.
    The Journal of investigative dermatology, 2022, Volume: 142, Issue:11

    Topics: Antitubercular Agents; Ethambutol; HIV Infections; Humans; Interferon-gamma; Isoniazid; Pyrazinamide

2022